This inventor holds 10 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignee: Glaxo Group Limited. Active years: 2006-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2013
Title: Simon Teanby Hodgson: Innovator in Pharmaceutical Compounds
Introduction
Simon Teanby Hodgson, an accomplished inventor based in Stevenage, GB, has made significant contributions to the field of pharmaceuticals. He holds a remarkable portfolio of 10 patents, showcasing his expertise and dedication to innovation in medicinal chemistry.
Latest Patents
Among Hodgson's latest patents are two notable inventions that focus on the development of novel compounds. The first patent covers "Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy." The second patent relates to "Pyrazole derivatives used as CCR4 receptor antagonists - Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy." These advancements highlight his impactful work in addressing therapeutic needs.
Career Highlights
Simon Teanby Hodgson has established himself as a key figure in the pharmaceutical industry through his role at Glaxo Group Limited. His innovative research has propelled the development of therapeutic agents that promise to improve patient outcomes and enhance treatment options in various medical areas.
Collaborations
In his career, Hodgson has collaborated with esteemed colleagues such as Paul Martin Gore and Xiao Qing Lewell. These professional relationships underscore the importance of teamwork in research and innovation, facilitating the exchange of ideas and expertise that drive successful outcomes.
Conclusion
In conclusion, Simon Teanby Hodgson stands out as a prolific inventor with a strong commitment to advancing pharmaceutical science. His patents reflect a deep understanding of medicinal chemistry and the potential for developing innovative therapies that can significantly benefit society. As he continues to work at Glaxo Group Limited, the impact of his contributions will undoubtedly shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile